CLDX - Celldex Therapeutics, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
No. of Analysts1111
Avg. Estimate-1.17-1.21-4.8-3.69
Low Estimate-1.17-1.21-4.8-3.69
High Estimate-1.17-1.21-4.8-3.69
Year Ago EPS-1.65-0.6-14.48-4.8
Revenue EstimateCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
No. of Analysts1111
Avg. Estimate1.26M1.26M5.1M6M
Low Estimate1.26M1.26M5.1M6M
High Estimate1.26M1.26M5.1M6M
Year Ago Sales2.76M941k9.54M5.1M
Sales Growth (year/est)-54.40%33.90%-46.50%17.60%
Earnings History6/29/20189/29/201812/30/20183/30/2019
EPS Est.-2.1-2.25-1.2-1.14
EPS Actual-1.65-0.6-0.81-1.4
Difference0.451.650.39-0.26
Surprise %21.40%73.30%32.50%-22.80%
EPS TrendCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
Current Estimate-1.17-1.21-4.8-3.69
7 Days Ago-1.17-1.21-4.8-3.69
30 Days Ago-1.17-1.21-4.8-3.69
60 Days Ago-1.13-1.18-4.69-3.6
90 Days Ago-0.14-0.13-6-5.55
EPS RevisionsCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesCLDXIndustrySectorS&P 500
Current Qtr.29.10%N/AN/A0.02
Next Qtr.-101.70%N/AN/A0.04
Current Year66.90%N/AN/A0.05
Next Year23.10%N/AN/A0.10
Next 5 Years (per annum)N/AN/AN/A0.10
Past 5 Years (per annum)N/AN/AN/AN/A